Clyde L. Schultz
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Clyde L. Schultz has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
Kathleen S. Kunert
1 shared publication
Latest Publications
- 1 March 2000
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 20 (3) , 309-310
Interleukin-6 Levels in Tears of Contact Lens Wearers
The purpose of this study was to evaluate the presence of interleukin-6 (IL-6) in basal tears of contact lens wearers (n = 18) and nonlens wearers (n = 25). Samples (5 mul) were collected with a micocapillary pipette and evaluated using PAGE electrophoresis and immunoblot analysis. Contact lens-wearing patients had a mean IL-6 level of 43.8 +/- 5.3 pg/5 mul compared with nondetectable IL-6 levels throughout the noncontact lens-wearing population. IL-6 in several patients removed from contact lens wear for 6 days became nondetectable. When these patients were returned to wearing lenses, IL-6 levels increased to their original levels within 24 h. The data presented indicate that an ocular medical device may stimulate IL-6 production.
- 1 March 2000
- Published by SAGE Publications in Journal of Interferon & Cytokine Research
- Vol. 20 (3) , 309-310
Interleukin-6 Levels in Tears of Contact Lens Wearers
The purpose of this study was to evaluate the presence of interleukin-6 (IL-6) in basal tears of contact lens wearers (n = 18) and nonlens wearers (n = 25). Samples (5 mul) were collected with a micocapillary pipette and evaluated using PAGE electrophoresis and immunoblot analysis. Contact lens-wearing patients had a mean IL-6 level of 43.8 +/- 5.3 pg/5 mul compared with nondetectable IL-6 levels throughout the noncontact lens-wearing population. IL-6 in several patients removed from contact lens wear for 6 days became nondetectable. When these patients were returned to wearing lenses, IL-6 levels increased to their original levels within 24 h. The data presented indicate that an ocular medical device may stimulate IL-6 production.